Your browser doesn't support javascript.
loading
Versatility of microbial transglutaminase.
Strop, Pavel.
Afiliação
  • Strop P; Rinat-Pfizer Inc. , 230 East Grand Avenue, South San Francisco, California 94080, United States.
Bioconjug Chem ; 25(5): 855-62, 2014 May 21.
Article em En | MEDLINE | ID: mdl-24694238
Although microbial transglutaminases (mTGs) were initially discovered to offset the cost of producing mammalian transglutaminases for food applications, they have quickly become important tools in research and biotechnology. Today, mTGs are utilized for a large number of applications to conjugate proteins and peptides to small molecules, polymers, surfaces, and DNA, as well as to other proteins. It is important to know how to maximize the advantages of the enzymatic approach and avoid undesired cross-linking. This review focuses on the versatility of transglutaminases in the field of bioconjugation and covers recent developments in utilizing mTG for generating antibody drug conjugates (ADCs) for therapeutic applications.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Streptomyces / Transglutaminases / Neoplasias Idioma: En Revista: Bioconjug Chem Assunto da revista: BIOQUIMICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Streptomyces / Transglutaminases / Neoplasias Idioma: En Revista: Bioconjug Chem Assunto da revista: BIOQUIMICA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos